SAFETY ASPECTS OF GH THERAPY IN TURNER SYNDROME (TS): NO EVIDENCE FOR VENTRICULAR HYPERTROPHY (VH) AND NORMALIZATION OF INSULIN LEVELS AFTER DISCONTINUATION OF GH. 572 | Zendy

AI Assistant Blog Pricing

SAFETY ASPECTS OF GH THERAPY IN TURNER SYNDROME (TS): NO EVIDENCE FOR VENTRICULAR HYPERTROPHY (VH) AND NORMALIZATION OF INSULIN LEVELS AFTER DISCONTINUATION OF GH. 572

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.